Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
programme designated to attract and empower the world’s brightest early-career researchers. This fellowship supports outstanding scientists who harness Artificial Intelligence (AI) to accelerate breakthroughs
-
to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate
-
Training Group (RTG) “Activation of anti-Microbial Effectors (ACME)” (coordinator: Dirk Schlüter, Hannover) funded by the German Research Foundation. The central aim of the program is to give highly
-
. Familiarity with statistical analysis software (e.g., STATA, R, SPSS) or computer programming (e.g. C++, Python, R) and experience working with health-related data will be advantageous. The ability to work
-
program. Position Summary The MacDonald Lab (www.bcell.org) at the Alberta Diabetes Institute would like to hear from postdoctoral candidates with a keen interest in advancing understanding of insulin and
-
Program . Job description The fellowships are aimed at early-career researchers with a basic science background or clinicians who aspire to a career in academia. We are particularly interested in candidates
-
The newly established Program for Memory Longevity (PML), led by Attila Losonczy, MD, PhD, in the O’Donnell Brain Institute (OBI) and the Department of Neuroscience at the University of Texas
-
and fuel cells. The research also includes the economic and life cycle analysis, and marketing plan of the fabricated GDL product, as well as identify the potential risks associated with the workplan
-
. The Postdoctoral Research Fellow will: Conduct a programme of research towards achieving one or more these goals. This will include contributing to the design of experiments, growth of the necessary plant material
-
oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor prognosis, and this clinic